Big Rock Partners Acquisition (Unit)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BRPAU and buy or sell other stocks, ETFs, and their options commission-free!About BRPAU
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C.
CEOJonathan C. Javitt, MD
CEOJonathan C. Javitt, MD
Employees—
Employees—
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded2017
Founded2017
Employees—
Employees—
BRPAU Key Statistics
Market cap1.11B
Market cap1.11B
Price-Earnings ratio-67.23
Price-Earnings ratio-67.23
Dividend yield—
Dividend yield—
Average volume36.10
Average volume36.10
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$89.00
52 Week high$89.00
52 Week low$10.20
52 Week low$10.20
Stock Snapshot
With a market cap of 1.11B, Big Rock Partners Acquisition (Unit)(BRPAU) trades at $40.00. The stock has a price-to-earnings ratio of -67.23.
On 2025-11-18, Big Rock Partners Acquisition (Unit)(BRPAU) stock opened at —, reached a high of —, and a low of —.
Big Rock Partners Acquisition (Unit)(BRPAU) shares are trading with a volume of 0, against a daily average of 36.1.
In the last year, Big Rock Partners Acquisition (Unit)(BRPAU) shares hit a 52-week high of $89.00 and a 52-week low of $10.20.
In the last year, Big Rock Partners Acquisition (Unit)(BRPAU) shares hit a 52-week high of $89.00 and a 52-week low of $10.20.